17626-40-3

Basic information

• Product Name: 3,4-Diaminobenzonitrile
• Synonyms: 1,2-DiaMino-4-cyanobenzene;2-AMino-4-cyanoaniline;4-Cyano-1,2-phenylenediaMine;4-Cyano-o-phenylenediaMine;4-Cyanobenzene-1,2-diamine, 4-Cyanophenylene-1,2-diamine;Benzonitrile,3,4-diaMino-;BUTTPARK 43\57-88;3,4-DIAMINOBENZONITRILE
• CAS NO: 17626-40-3
• Molecular Formula: C₇H₇N₃
• Molecular Weight: 133.15
• EINECS: 1533716-785-6
• Product Categories: Organic Building Blocks;Phenyls & Phenyl-Het;Nitrile;heterocyclic/Aliphatic series;Heterocyclic Compounds;Neurochemicals;Phenyls & Phenyl-Het;C6 to C7;Cyanides/Nitriles;Nitrogen Compounds;Building Blocks;C6 to C7;Chemical Synthesis;Nitrogen Compounds
• Mol File: 17626-40-3.mol

Chemical Properties

• Melting Point: 144-148 °C
• Boiling Point: 368.7 °C at 760 mmHg
• Flash Point: 176.8 °C
• Appearance: Pale brown/Solid
• Density: 1.24 g/cm³
• Vapor Pressure: 1.25E-05mmHg at 25°C
• Refractive Index: 1.64
• Storage Temp.: Amber Vial, -20?C Freezer
• Solubility: Soluble in dichloromethane, methanol and ethyl acetate.
• PKA: 2.35±0.10(Predicted)
• Stability: Store in freezer at -20°C
• CAS DataBase Reference: 3,4-Diaminobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Diaminobenzonitrile(17626-40-3)
• EPA Substance Registry System: 3,4-Diaminobenzonitrile(17626-40-3)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 22-36/37/38-20/21/22
• Safety Statements: 26-36-36/37
• RIDADR: 3276
• WGK Germany: 3
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 17626-40-3(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
3,4-Diaminobenzonitrile is used as a synthetic intermediate for the production of various chemicals and materials. Its chemical properties make it a versatile compound in the synthesis of different products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3,4-Diaminobenzonitrile is used as a synthetic intermediate for the development of various drugs. Its unique structure allows for the creation of new compounds with potential therapeutic applications.
Used in Dye Manufacturing:
3,4-Diaminobenzonitrile is also used in the dye manufacturing industry as a synthetic intermediate. Its properties enable the production of a wide range of dyes with different colors and characteristics.
Used in Agrochemicals:
In the agrochemical industry, 3,4-Diaminobenzonitrile is utilized as a synthetic intermediate for the development of various agrochemical products, such as pesticides and fertilizers, which are essential for agricultural productivity.
Overall, 3,4-Diaminobenzonitrile is a valuable compound in the chemical industry due to its diverse applications as a synthetic intermediate across various sectors, including pharmaceuticals, dyes, and agrochemicals.

InChI:InChI=1/C7H7N3/c8-4-5-1-2-6(9)7(10)3-5/h1-3H,9-10H2

Upstream product

• 6393-40-4 4-Amino 3-nitro-benzonitrile 
• 89642-49-9 4-bromo-3-nitrobenzonitrile 
• 875-51-4 4-Bromo-2-nitroaniline 
• 99512-10-4 3-amino-4-nitrobenzonitrile 
• 7732-18-5 water 
• 29289-18-7 N-(4-cyano-2-nitrophenyl)acetamide 
• 35704-19-9 N-(4-cyanophenyl)acetamide 
• 873-74-5 4-Aminobenzonitrile 
• 7647-01-0 hydrogenchloride 

Downstream Products

• 92443-13-5 2-methyl-1H-benzoimidazole-5-carbonitrile 
• 125103-77-7 2-[2-(4-Chloro-phenyl)-2-oxo-eth-(E)-ylidene]-3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carbonitrile 
• 117836-60-9 1-(4-Nitro-phenyl)-2-phenyl-1,1a-dihydro-3,7b-diaza-cyclopropa[a]naphthalene-5-carbonitrile 
• 117836-58-5 1,2-Diphenyl-1,1a-dihydro-3,7b-diaza-cyclopropa[a]naphthalene-5-carbonitrile 
• 125103-80-2 2-Oxo-3-[2-oxo-2-p-tolyl-eth-(E)-ylidene]-1,2,3,4-tetrahydro-quinoxaline-6-carbonitrile 
• 105273-92-5 2-Methyl-2,4-bis-(4-nitro-phenyl)-2,3-dihydro-1H-benzo[b][1,4]diazepine-7-carbonitrile 
• 125103-76-6 3-Oxo-2-[2-oxo-2-p-tolyl-eth-(E)-ylidene]-1,2,3,4-tetrahydro-quinoxaline-6-carbonitrile 
• 125103-78-8 2-[2-(4-Bromo-phenyl)-2-oxo-eth-(E)-ylidene]-3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carbonitrile 
• 158667-62-0 2-(3-iodophenyl)-1H-benzimidazole-5-carbonitrile 
• 158667-61-9 2-(2-iodophenyl)-1H-benzimidazole-5-carbonitrile 
• 158667-64-2 2-(4-dimethylaminophenyl)-1H-benzimidazole-5-carbonitrile 
• 159277-30-2 2-(2-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-ethyl)-3H-benzoimidazole-5-carbonitrile 
• 159277-31-3 2-(3-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-propyl)-3H-benzoimidazole-5-carbonitrile 
• 167959-14-0 5-cyano-2-(p-methoxyphenyl)benzimidzole 

Relevant articles and documents

1-Aryl-3-(4-methoxybenzyl)ureas as potentially irreversible glycogen synthase kinase 3 inhibitors: Synthesis and biological evaluation

Glycogen synthase kinase 3 (GSK-3)has become known for its multifactorial involvement in the pathogenesis of Alzheimer's disease. In this study, a benzothiazole- and benzimidazole set of 1-aryl-3-(4-methoxybenzyl)ureas were synthesised as proposed Cys199-targeted covalent inhibitors of GSK-3β, through the incorporation of an electrophilic warhead onto their ring scaffolds. The nitrile-substituted benzimidazolylurea 2b (IC50 = 0.086 ± 0.023 μM)and halomethylketone-substituted benzimidazolylurea 9b (IC50 = 0.13 ± 0.060 μM)displayed high GSK-3β inhibitory activity, in comparison to reference inhibitor AR-A014418 (1, IC50 = 0.072 ± 0.043)in our assay. The results suggest further investigation of 2b and 9b as potential covalent inhibitors of GSK-3β, since a targeted interaction might provide improved kinase-selectivity.

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Cyanato - benzimidazole salt and its preparation method

The present invention discloses a new metal cyano-substituted benzimidazolide salt having formula (I) and its preparation. This new cyano-substituted benzimidazole derivatives exhibited excellent thermal stability. The organic salt of the present inventio

Synthesis and potent antiprotozoal activity of mono/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense

A series of mono and dicationic new 2-anilinobenzimidazole carboxamidines were prepared in a four step process starting from 4-amino-3-nitrobenzonitrile and corresponding o-phenylenediamines. Their antiparasitic activity against Plasmodium falciparum (P.

NOVEL BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to a novel benzimidazole compound, a pharmaceutical composition for preventing or treating an inflammatory disease comprising said compound, a use of a novel benzimidazole compound for the manufacture of a medicament for prev

Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-Aryl-substituted 2-bis-1H-benzimidazoles

Inhibitors of topoisomerase I constitute a novel family of antitumor agents. The class of benzimidazole derivatives contains compounds possessing affinity to DNA. For example, fluorescent stains Hoechst 33342 and Hoechst 33258 interact with DNA as ligand

HETERO COMPOUND

[Problems] To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 a

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:

7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).